Archive for September, 2016

« Previous Entries

DHA Might Help Prevent Systemic Lupus Erythematosus

Friday, September 30th, 2016

Docosahexaenoic acid (DHA for short) might be able to prevent systemic lupus erythematosus (SLE for short). DHA is a type of omega-3 and SLE is the most common form of lupus, which is an autoimmune disease. There are three types of Omega-3, one of which is DHA, present in fatty fish, like trout, tuna, and […]

Some NSAIDs Increase Risk of Heart Failure, Study Reveals

Thursday, September 29th, 2016

A new study has linked NSAIDs with increased risk of hospital admission for heart failure. The study has also identified seven widely-used non-steroidal anti-inflammatory drugs (NSAIDs) that increase this risk and shows that the risk increases significantly when NSAIDs are taken at very high dose. NSAIDs are prescribed for reducing inflammation. This class of drugs […]

Mediterranean Diet Reduces Cardiovascular Disease Risk

Wednesday, September 28th, 2016

The health benefits of Mediterranean diet are well documented. A new study has attributed another benefit to this healthy diet. It states following Mediterranean diet might help lower your risk of heart attack, heart disease, stroke, and other cardiovascular disease. Cardiovascular disease is an umbrella term which involves diseases affecting the heart and blood vessels. […]

High Zinc Intake Linked to Clostridium difficile infection

Tuesday, September 27th, 2016

You carry a greater risk to Clostridium difficile infection if your intake of zinc is higher than normal, especially when you are also on antibiotics, according to a recent research. Clostridium difficile infection has a high death rate. In 2011, nearly 500,000 people in the US were infected by it. Among these, approximately 29,000 people […]

Hypertension Drugs Can Significantly Reduce Cerebral Malaria Deaths

Monday, September 26th, 2016

Including an angiotensin influencing drug, which is used for control blood pressure, improved survival rate in malaria infected mice by three times, according to a new research. While malaria, a life-threatening blood disease caused by a mosquito bite, has been long since eradicated in the US, hundreds of thousands of cases of malaria deaths are […]

An Experiment Drug Might Prevent Multiple Sclerosis

Sunday, September 25th, 2016

According to a new research, an experimental drug called laquinimod might stop the progression of multiple sclerosis (MS for short), a lifelong condition that worsens with time and for which there’s no cure at present. It is estimated that there are 2.5 million people affected by MS worldwide. In the US alone, nearly 400,000 people […]

Ilaris Gains FDA Approval for Three New Indications

Saturday, September 24th, 2016

The FDA has approved Ilaris for 3 new indications, each a rare auto inflammatory condition. Ilaris has obtained approval for the following 3 indications: · Familial Mediterranean Fever · Mevalonate Kinase Deficiency · Tumor Necrosis Factor Receptor Associated Periodic Syndrome Each of these conditions is hereditary. Patients of all three conditions experience severe pain in […]

FDA Gives Approval to Amjevita

Friday, September 23rd, 2016

The FDA has given approval to Amjevita. The drug is biosimilar to Humira. Amjevita has received FDA’s approval as a biosimilar for more than one inflammatory condition. Amjevita has received FDA’s approval for treating adult patients with: · Rheumatoid arthritis · Ankylosing spondylitis · Psoriatic arthritis · Plaque psoriasis · Crohn’s disease · Ulcerative Colitis […]

Nicotine Might Prevent Neurodegeneration

Thursday, September 22nd, 2016

According to a new study, nicotine might be effective in reducing neurodegeneration. Nicotine is an addictive chemical in tobacco, whose intake is linked with many health conditions. Cognitive benefits of nicotine are attributed to its ability to bind with and activate certain receptors inside the brain, called nicotinic acetylcholine receptors. How nicotine does that is […]

Environmental Conditions Might Influence Efficacy of Depression Medication

Wednesday, September 21st, 2016

Selective serotonin reuptake inhibitors (SSRIs) are the most common type of antidepressants. While an effective treatment for depression, SSRIs don’t work for everyone. Until now there was no way to tell in which case the SSRI treatment is likely to work and in which case not. Thankfully, a new study sheds some light on this. […]

« Previous Entries